Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial

Publisher： Karger

E-ISSN： 1421-9832|222|1|36-48

ISSN： 1018-8665

Source： Dermatology, Vol.222, Iss.1, 2010-12, pp. : 36-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of the Antipruritic Effects of Topical Pimecrolimus in Non-Atopic Prurigo Nodularis: Results of a Randomized, Hydrocortisone-Controlled, Double-Blind Phase II Trial

By  

Dermatology, Vol. 227, Iss. 4, 2013-11 ,pp. : 353-360

Karger

Access to resources Recommend Favorite

Rosaceiform Dermatitis with Follicular Demodex after Treatment of Facial Atopic Dermatitis with 1% Pimecrolimus Cream

By  

Dermatology, Vol. 207, Iss. 2, 2003-08 ,pp. : 205-207

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Pimecrolimus Cream 1% in Mild-to-Moderate Chronic Hand Dermatitis: A Randomized, Double-Blind Trial

By  

Dermatology, Vol. 221, Iss. 1, 2010-06 ,pp. : 71-77

Karger

Access to resources Recommend Favorite

Steroid-Sparing Effect of Pimecrolimus Cream 1% in Children with Severe Atopic Dermatitis

By  

Dermatology, Vol. 215, Iss. 4, 2007-10 ,pp. : 325-330

Karger

Access to resources Recommend Favorite

Percutaneous Absorption of Pimecrolimus Is Not Increased in Patients with Moderate to Severe Atopic Dermatitis when Pimecrolimus Cream 1% Is Applied under Occlusion

By  

Dermatology, Vol. 221, Iss. 4, 2010-11 ,pp. : 342-351

Karger

Access to resources Recommend Favorite